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Abstract
Background: Activin A increases production of follicle stimulating hormone (FSH) by inducing
transcription of its beta subunit (FSHB). This induction has been studied here in LbetaT2
gonadotropes using transient expression of ovine FSHBLuc (-4741 bp of ovine FSHB promoter plus
exon/intron 1 linked to Luc). Several sequences between -169/-58 bp of the ovine FSHB proximal
promoter are necessary for induction by activin A in LbetaT2 cells, but deletions between -4741/-
752 bp decrease induction > 70% suggesting the existence of other important 5' sequences.
Induction disappears if a minimal T81 thymidine kinase promoter replaces the ovine FSHB TATA
box and 3' exon/intron. The study reported here was designed to determine if sequences outside
-169/-58 bp are important for induction of ovine FSHB by activin A.
Methods: Progressively longer deletions of ovine FSHBLuc were created between -4741/-195 bp.
Deletions internal to this region were created also, but replaced with substitute DNA. The ovine
FSHB TATA box region (-40/+3 bp) was replaced by thymidine kinase and rat prolactin minimal
promoters, and substitutions were made in 3' intron/exon sequences. All constructs were tested
for basal and activin A-induced expression in LbetaT2 cells.
Results: Successive 5' deletions progressively lowered fold-induction by activin A from 9.5 to zero,
but progressively increased basal expression. Replacing deletions with substitute DNA showed no
changes in basal expression or fold-induction. Induction by activin A was supported by the minimal
rat prolactin promoter (TATA box) but not the thymidine kinase promoter (no TATA box).
Replacement mutations in the 3' region did not decrease induction by activin A.
Conclusion: The data show that specific ovine FSHB  sequences 5' to -175 bp or 3' of the
transcription start site are not required for induction by activin A. A minimal TATA box promoter
supports induction by activin A, but the sequence between the TATA box and transcription start
site seems unimportant.
Background
Follicle stimulating hormone (FSH) is made only in pitu-
itary gonadotropes and stimulates gonads for normal
reproductive function in females and males [1-3]. Tran-
scription of the gene encoding FSH beta subunit (FSHB)
is rate limiting for overall hormone production, and the
most potent and influential direct inducer of FSH produc-
tion is in the activin family [4,5]. Activin A is used to study
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FSHB regulation in most studies. Significant research has
focused on classical Smad activation by activin A and its
down-stream signals leading to FSHB expression, but the
evidence for Smad involvement with ovine FSHB is not
yet clear [6,7].
A complementary approach to understanding activin A
signaling is to identify promoter sequences required for
induction. The standard approach for these studies is to
analyze transient expression of FSHB promoter/reporter
gene constructs in transformed murine gonadotropes
(LbetaT2 cells). The construct used by our laboratory to
study regulation of ovine FSHB is ovine FSHBLuc (-4741
bp of ovine FSHB promoter plus exon/intron 1 linked to
the luciferase gene; see Figure 1).
Transgenic studies recently confirmed that a Smad-related
site between -169/-158 bp of the ovine promoter is
required for ≥ 99% of ovine FSHB expression in vivo [7].
This site was first discovered using transient expression of
ovine FSHBluc mutants in LbetaT2 cells [8]. More recently
transgenic studies were used to confirm the importance of
a Pitx1/2 site between -68/-63 bp required for 99% of
ovine FSHBLuc expression in vivo. This site may have no
connection with activin A action in the ovine gene (Sang-
oh Han, manuscript in review; our laboratory), but seems
to in rodent FSHB expression [9,10]. This site is conserved
in all mammals studied to date and was first reported to
be important using rodent FSHB-reporter constructs
[9,10]. A third site (Pbx1) is reported to be important for
induction by activin A in LbetaT2 cells [8]. Thus, a
number of sites in the FSHB promoter seem necessary for
FSHB expression and, perhaps, regulation in vivo.
Interestingly, 5' truncations of rodent FSHBLuc constructs
are reported to decrease induction by activin A in LbetaT2
cells [11,12]. Truncations from -1990 to -304 bp in mouse
constructs reduced fold-induction by 60%. Similar studies
with ovine FSHBLuc showed that a deletion from -4741 to
-750 bp decreased fold-induction by 70% (Pei Su; unpub-
lished results; our laboratory). One interpretation of these
data is that there are specific sequences in the 5' region
important for activin A action.
Finally, ovine FSHB promoter sequences between -4741/-
39 bp do not support activin A induction when placed
behind the minimal T81 thymidine kinase promoter (Pei
Su, unpublished results; our laboratory). By contrast, four
copies of the palindromic Smad binding site of the
murine FSHB promoter do confer activin A induction on
a minimal TK promoter/luciferase construct (≥ 10-fold
induction) [13]. These results suggest differences between
activin A induction of the rodent and ovine genes. One
difference could involve the exon and intron that are
included in the ovine FSBHLuc construct. Alternatively, it
could reflect a differential need for a TATA box promoter
in the ovine and rodent genes. To date, the 3' ovine intron
has been considered important only for basal gene expres-
sion by making mRNA processing more efficient and/or
effective, but it might also contain sequences needed for
activin A induction. Therefore, it is possible that
sequences either in the TATA box region or 3' exon/intron
region of the ovine FSHB gene play an important role in
activin A induction.
The study reported here examined the 5', 3' and TATA box
regions of the ovine FSHB  gene to determine which
regions outside of -169/-58 bp are important for induc-
tion by activin A.
Methods
Reagents and constructs
Recombinant human activin A was purchased from R&D
systems (Minneapolis, MN). FuGENE®6 transfection rea-
Diagram of the wild type ovine FSHBLuc promoter/reporter construct Figure 1
Diagram of the wild type ovine FSHBLuc promoter/reporter construct. The wild type ovine FSHBLuc expression plas-
mid is shown including -4741 bp of 5' promoter, TATA box (-31/-26 bp), exon 1 (1/63 bp), intron 1 (64/702 bp), part of exon 
2 (703/765 bp) and firefly luciferase gene. Regions known to be important for ovine FSHBLuc expression are marked: a putative 
Smad binding site (-163/-159 bp) [7,8], Pbx1 binding site (-136/-131 bp) [8], Pitx1 binding site (-68/-63 bp) [9,10].
-167GTTTAGAC-159
(putative SBE)
-4741 Intron1 Exon1 TATA
Luc
-68AAATCC-63
(Pitx1 Binding Site)
-136CTGTCT-131
(Pbx1 Binding Site)Reproductive Biology and Endocrinology 2009, 7:66 http://www.rbej.com/content/7/1/66
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gent was purchased from Roche Applied Science (Indian-
apolis, IN) and QuikChange® Site-Directed Mutagenesis
kits were obtained from Agilent Technologies Co. (La
Jolla, CA). Restriction enzymes including BglII, KpnI, SacI,
SacII, Acc65I, AgeI, XhoI, HindIII, and EcoRI as well as
dual luciferase assay kits were purchased from Promega
(San Luis Obispo, CA). All plasmids were purified using
Qiagen midi-prep kits (Qiagen, Valencia, CA). Dulbecco's
modified eagle medium (DMEM) and fetal bovine serum
were purchased from Invitrogen (Carlsbad, CA). All prim-
ers for point mutations were obtained from Sigma-Aldrich
Co. (St. Louis, MO). Mutated sections for all plasmids
were sequenced by SeqWright Technology (Houston, TX)
to confirm sequence correctness, and all common rea-
gents such as yeast extract, tryptone, agar, Tris and boric
acid were purchased from Fisher Scientifc Inc. (Pittsburgh,
PA). The ovine FSHBLuc plasmid used throughout this
study (-4741 bp of 5' promoter plus intron 1 linked to a
luciferase reporter gene in a pGL3 plasmid) was the same
as that reported earlier [14]. Nearly 10 kb of human FSHB
gene sequence (-3511/+5918 bp) was provided by Dr. T.
Rajendra Kumar (University of Kansas Medical Center,
Kansas City, KS).
Transfections in LbetaT2 cells and reporter assays
Immortalized murine gonadotropes (LbetaT2 cells) were
obtained from Dr. Pamela Mellon (University of Califor-
nia, San Diego, CA) and maintained in complete DMEM
containing 10% (v/v) fetal bovine serum plus 100 μg/ml
streptomycin and 100 U/ml of penicillin at 37°C under
5% CO2: 95% air. For experiments, cells were plated at a
density of 30,000 cells in 50 μl of complete media in 96-
well tissue culture plates. Cells were transfected 24 hr after
plating in quadruplicate by adding 50 μl of serum-free
media containing 50 ng plasmid plus 0.15 μl Fugene6.
The molecular weights of plasmids with deletions varied
significantly (Figures 2 &3) so equal molar amounts of
test plasmid were transfected into cells with the weight
difference made up by the empty vector.
Cells were co-transfected with 5 ng/well pRL-TK which
was used as an internal control since its production of
Renilla luciferase was not altered by activin A treatment.
After 24 hr of transfection, the media were changed and
cells were treated with or without 25 ng/ml activin A for
22 hr prior to harvest with 20 μl of passive lysis solution.
Firefly and Renilla luciferase activities were quantified
sequentially using a Victor-Light micro plate luminometer
(PerkinElmer, Waltham, MA). Assays were performed
according to the manufacturer's recommendations.
Briefly, 10 μl of cell lysates were pipetted into Costar 96-
well half-area microplates (Corning; white; 3693) and 25
μl of firefly luciferase substrate was added for detecting
firefly luciferase activity (20 seconds/sample). Luciferase
activity was always 40–20,000 × machine background
(~400 RLU). After assaying the plate for firefly luciferase,
25 μl of Renilla luciferase substrate plus Stop and Glow
was added to specifically detect Renilla luciferase activity.
All Renilla activities were 8–100× machine background
(~300 RLU) depending on culture preparation. Within
individual assays, Renilla activity varied ≤ 10% indicating
little variation in transfection efficiency between cultures
and/or plasmid preparations. Corrected luciferase activity
was calculated by dividing firefly luciferase by Renilla
activity and was reported as the ratio of Luciferase/Renilla.
Basal activity is defined as activity without activin A treat-
ment. Basal and activin A-induced activities are reported
in Figure 3. Fold-induction plotted in Figure 2 was calcu-
lated by dividing activin A-induced activity by basal activ-
ity shown in Figure 3.
Deletion constructs in the 5' promoter of ovine FSHBLuc
A series of KpnI restriction sites was created by making
point mutations at -4042, -3387, -2362, -1966, -1440, -
1015, -546, -195 bp in ovine FSHBLuc. Subsequent Kpn1
digestions cut out sequences between these sites and the
formerly unique Kpn1 site at -4793 bp of ovine FSHBLuc.
Re-ligation created 8 of 11 total deletion mutants. Two of
the remaining deletions utilized ApaI and EcoRI restric-
tion sites already present in ovine FSHBLuc (ApaI at -4786
and -2932 bp; EcoRI at -4744 and -306 bp). The last dele-
tion mutant was made by creating a SacI site at -4775 bp.
Subsequent deletion with SacI cut out the fragment
between -4775 bp and an existing SacI site at -748 bp. The
plasmid was then re-ligated. All mutants were sequenced
to verify their structure.
Replacement constructs in the 5' promoter of ovine 
FSHBLuc
Point mutations were made to create restriction sites used
to excise and replace promoter sequences in ovine FSHB-
Luc. All restriction site mutants were tested to show they
had no effect on either expression or activin A-mediated
induction of the construct. Replacement 1 (Rep1) was
made by replacing -4793/-4043 bp with -1965/-1218 bp
using the Kpn1 restriction sites at -4793 and -1965 (see
above) and newly made AgeI sites at -4043 and -1218.
Replacement 2 (Rep2) was made by replacing -4043/-
2760 bp with -2028/-744 bp of ovine FSHBLuc using AgeI
and BglII restriction sites. Replacement 3 (Rep3) was
made by replacing -2760/-2028 bp with +5/+740 bp using
BglII and SacII restriction sites. Replacement 4 (Rep4) was
constructed by replacing -2028/-744 bp with -4043/-2760
bp after creating AgeI and BglII sites. Replacement 5
(Rep5) was constructed by replacing -750/-175 bp with -
3341/-2760 bp after creating SacII and BglII sites. Replace-
ment 6 (Rep6) was constructed by replacing -90/-39 bp of
ovine FSHBLuc  with a synthetic oligonucleotide of the
same size in which A and T were exchanged for C and G.
The sequence was inserted using AgeI and BglII sites at -90Reproductive Biology and Endocrinology 2009, 7:66 http://www.rbej.com/content/7/1/66
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bp and -39 bp, respectively. Rep6 lacks the Pitx1 site
known to be important for rodent and ovine FSHBLuc
expression and was included as a negative control
expected to show low expression and/or low induction by
activin A in LbetaT2 cells. Replacement 7 (Rep7) was con-
structed by replacing sequences at -24/-3 bp, just down-
stream of the TATA box. The synthetic replacement
sequence (random sequence) had a BglII site at the 5' end
(see sequence below, lower case) followed by the wild
type TATAAA box (bold); an MluI site (lower case) was
added at the 3' terminus (-39 agatctTGTATAAACAA-
GAACAAGAAATGCAacgcgt-3).
Replacement constructs in 3' ovine FSHBLuc (1 to 701 bp)
Replacement 8 (Rep8) removed exon 1 from ovine FSHB-
Luc (+7/+58 bp) and replaced it with a sequence contain-
ing BglII at +5 bp and SacII at +62 bp; the new sequence
was synthetically made by substituting original nucle-
otides as follows: A to C and T to G. Replacement 9 (Rep
9) removed intron 1 from ovine FSHBLuc (+83/+660 bp)
and replaced it with sequences between -3343 and -2760
bp of the ovine FSHB promoter using SacII and BglII sites
as done with Rep 5 (see above). This strategy preserved
sequences normally associated with splicing such as the
GU adjacent to exon 1 and the AG and associated adeno-
sine located several nucleotides upstream of the 5' end of
exon 2 [15].
Thymidine kinase promoter constructs
The pT109Luc plasmid, containing 109 bp of the herpes
simplex thymidine kinase promoter, was purchased from
the American Type Culture Collection (Manassa, VA).
Production of ovine FSHB(TK)Luc involved substituting
the promoter of pT109Luc (-132/+52 bp; named TK in
this report) for the same region in ovine FSHBLuc. First,
AgeI and BglII restiriction sites were created at -40 bp and
+3, respectively, in the wild type ovine FSHBLuc plasmid.
An AgeI restriction site was also created at -132 bp of the
Deletions: promoter length, fold-induction and relative basal expression Figure 2
Deletions: promoter length, fold-induction and relative basal expression. A series of deletions from -4741 bp to -
195 bp produced shorter and shorter lengths of 5' ovine promoter. Promoter length in each construct is plotted proportion-
ately. Opposite each deletion is either the "fold-induction" or basal expression associated with the construct presented as the 
mean ± sem of quadruplicates in one complete and representative experiment. # designates the bp at the 5' terminus of the 
deletion. Means with different symbols are statistically different from each other according to analyses by ANOVA followed by 
Tukey's multiple comparison test using P ≤ 0.05.
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pT109Luc plasmid and then sequences between AgeI and
an existing BglII site in the pT109Luc promoter were cut
and the pT109 promoter (-132/+52 bp) was substituted
for wild type sequences in ovine FSHBLuc.
Rat prolactin promoter constructs
Dr. Richard N. Day (University of Virginia, Charlottes-
ville, VA) provided 6XCRE-37PRL-Luc which contains 6
copies of a consensus cyclic AMP response element linked
to the minimal rat prolactin promoter. Production of
ovine FSHB(rPRL)Luc involved substituting the minimal
promoter of 6XCRE-37PRL-Luc (-44/+3 bp; abbreviated
rPRL in this report) for the same region of ovine FSHBLuc.
In this case, BglII and AgeI restriction sites were created at
-39 bp and +3 bp, respectively, in ovine FSHBLuc and
BglII and AgeI sites were created at -44 bp and +3 bp,
respectively, in 6XCRE-37PRL-Luc. This allowed substitu-
tion of the minimal rat prolactin promoter for the equiv-
alent wild type promoter sequence in ovine FSHBLuc.
Production of ovine Δ-175/-39 FSHB(rPRL)Luc involved
creating a BglII site at -175 bp of ovine FSHB(rPRL)Luc
followed by digestion with BglII which excised sequences
between -175 and -39 bp. The construct was re-ligated to
produce ovine Δ-175/-39  FSHB(rPRL)Luc. Replacement
10 (Rep10) was constructed from ovine FSHB(rPRL) by
replacing sequences between KpnI (-4793 bp) and EcoRI
(-207 bp) with human coding sequence between +1049/
+5939 bp. An EcoRI site was put into ovine FSHB(rPRL)
at -207 bp and the large segment between KpnI (-4793
bp) and EcoRI was excised from the construct. The human
sequence was obtained from human FSHB-GEM3 after
creating an EcoRI site at +5939 and using an existing
ACC651 site at +1049 bp (compatible with KpnI) of
human FSHB-GEM3. These sites were cut with Acc65I and
EcoRI and the resulting fragment was ligated into ovine
FSHB(rPRL)  to produce Rep 10. All constructs were
sequenced for verification of structure.
Statistics
All experiments were repeated 3 times or more with simi-
lar results. LbetaT2 cells respond with significant variation
to activin A over time, so pooling results from different
experiments makes it very difficult if not impossible to
show statistical differences from different constructs or
treatments. Therefore, results are plotted as representative
data from one complete experiment performed with
quadruplicate cultures. For Figures 2, 3 and 5A/B, statisti-
cal comparisons between multiple samples were accom-
Deletions: basal expression and induction by activin A Figure 3
Deletions: basal expression and induction by activin A. The raw data used to create Figure 2 are shown. These data 
were corrected using co-expression of Renilla, but Renilla expression varied ≤ 10% across all samples. Data represent the 
means ± sem of quadruplicates in one complete and representative experiment. # on the x-axis designates the bp at the 5' ter-
minus of the deletion.
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plished using ANOVA followed by Tukey's multiple
comparison test. For Figure 4, statistical comparisons
between multiple samples were performed using ANOVA
followed by Student Newman-Kuels analysis. Statistical
calculations were performed using Prism version 4
(GraphPad software, Inc., San Diego, CA)
Results and discussion
Ovine FSHB promoter sequences between -4741/-175 bp 
were not required for activin A induction
Important 5' promoter sequences between -169/-158 bp
and -68/-63 bp were previously identified by a number of
researchers using small targeted deletions in conserved
regions of rodent or ovine FSHB promoters. Their identi-
fication did not involve large scale 5' deletions, and the
importance of these specifically targeted regions has been
documented in vitro and partly in vivo as outlined in the
Background section.
Deletion studies with the 5' FSHB promoters of mouse
[11] or ovine (Pei Su; unpublished results; our laboratory)
also revealed major changes in fold-induction by activin
A. Studies in 2001 showed that a deletion between -4741/
-750 bp in the 5' promoter of ovine FSHBLuc (Figure 1)
decreased activin A induction of this construct by 70% in
LbetaT2 cells. This deletion also increased basal expres-
sion 14×. These results suggested that an important
silencer might be in this region. This study was initiated to
explore this possibility. As a result, many sequential dele-
tions were made between -4741/-195 bp. All these dele-
tions were upstream of the known response elements
between -169/-58 bp.
Replacement mutations between -4741/+701 bp of ovine FSHBLuc Figure 4
Replacement mutations between -4741/+701 bp of ovine FSHBLuc. Ovine FSHBLuc was divided into 9 sections to 
determine where activin-responsive sequences might be located. For replacement constructs 1–5, deleted regions are desig-
nated with a box that indicates what sequences were substituted for the deletion. For replacement constructs 6–9, the section 
deleted and replaced is written above the promoter line. The replacement sequences for 6–9 are identified in Materials and 
Methods. Fold-induction was calculated as a ratio of luciferase expression ± activin A corrected for Renilla co-expression. This 
Luciferase/Renilla ratio was 54 for WT induction. Basal expression was calculated the same way and normalized to wild type 
basal expression (WT = 1). The ratio of Luciferase/Renilla was 10 for WT basal expression. Bars represent the mean ± sem of 
results from quadruplicate cultures from a single but representative complete experiment. Means with different letters are sta-
tistically different from wild type induction (fold-induction). Means with different symbols are statistically different from wild 
type basal expression (relative basal expression). ANOVA and Student Newman-Keuls analyses were used to determine signif-
icance between means using P ≤ 0.05.
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The deletion data in Figure 2 indicate that "fold-induc-
tion" progressively decreased from 9.5-fold to zero induc-
tion as promoter length shortened. This was considered
odd because we already knew that sequences downstream
of -195 bp were important, but the data suggested either
that important 5' sequences existed upstream of -195 bp
or that plasmid artifacts had been generated. Plotting pro-
moter length versus "fold-induction" highlighted the
direct progressive correlation between promoter length
and fold-induction (Figure 2). No single deletion or even
pair of deletions caused a significant decrease in fold-
induction although fold-induction steadily decreased
with apparent loss of activin A effectiveness. As noted in
2001 (Pei Su), an opposite effect was observed for basal
expression which increased as promoter size decreased
(Figure 2). A significant increase occurred when sequences
between -1966/-748 bp were deleted suggesting that a
silencer might reside in this 1218 bp region, but no signif-
icant change occurred in basal expression when sequences
between -4042/-2362 were deleted indicating there were
no potential silencers in this more distal region.
Figure 3 depicts the raw data used to generate Figure 2. In
fact, all data in Figure 2 can be calculated from Figure 3,
but Figure 3 does not show the tight relationships that
exist between fold-induction, basal expression and pro-
moter length. Figure 3 does show, however, that activin A-
induced expression was relatively constant for all con-
structs compared to basal expression. Shorter constructs (-
1996 to -195) did express slightly better with activin A
treatment, however, than the longer constructs.
Based on the data in Figures 2 and 3, it could be postu-
lated that deletions eliminated a silencer between -1966/-
748 bp. If this were so, deletion relieved tonic repression
of FSHBLuc and the need/ability of activin A to overcome
it. The region between -1966/-748 bp would then be very
important for regulation of FSHB by activin A in vivo.
However, the gentle decline in "fold-induction" and
increase in basal expression also suggested a non-specific
effect.
To test these two hypotheses, 5 deletions were created and
replaced with substitute sequences of equivalent length
DNA to preserve original spacing in the plasmid (Figure 4,
see WT versus replacements 1–5). Replacements 2 and 4
(Figure 4) were made specifically to test the hypothesis
that a silencer might reside between -1966/-748 bp since
basal expression increased significantly when this section
was deleted. Replacement 2 contained two copies of this
putative "silencer" region. By contrast, Replacement 4
entirely lacked the putative "silencer" region and con-
tained two copies of sequences between -4043 and -2760
which showed no effect on basal expression when they
were deleted. The results shown in Figure 4 indicate that
both "fold-induction" and basal expression for these two
replacement constructs were statistically identical when
compared to each other by ANOVA and Student New-
man-Kuels analyses. Therefore, it was concluded that a
silencer does not exist in the -1966/-748 bp region. Like-
wise, sequences between -4043/-2760 contained no spe-
cial sequences associated with activin A induction.
Other replacement DNA sequences came from a coding
sequence or other parts of the ovine FSHB promoter, but
all of these constructs had similar basal and activin A-
induced expression. Because major changes in fold-induc-
tion by activin A disappeared when construct size was
maintained, it was concluded that changes in fold-induc-
tion due to progressive 5' deletions was an artifact caused
by some non-specific effect (see discussion at the end of
this section).
The above results and discussion about the distal ovine
promoter are not meant to imply that 5' sequences have
no relevance for FSHB expression. Transgenic studies with
full length and truncated ovine FSHBLuc constructs indi-
cate that 5' sequences somewhere between -2100 bp and -
750 bp are needed for pituitary expression in vivo [14].
Kato et al also reported that Prop 1 binding sites between
-852/-746 bp in the porcine FSHB promoter are required
for expression in vivo [16,17], and the ovine FSHB pro-
moter shares high homology with this porcine promoter
region. The data in Figures 2, 3, 4 of this report were
focused on activin A induction of ovine FSHBLuc  in
LbetaT2 cells, but it appears that LbetaT2 cells cannot
detect all sequences required for gonadotrope expression
in vivo.
Interestingly, other investigators have found results that
are almost identical to those observed by us using progres-
sive deletions, but with different gene promoters. These
investigators also concluded that 5' silencers must exist
which means they will also design experiments to find
silencers. One research group also used a pGL3 plasmid
(like ours) for investigating expression of the rodent
selenoprotein W [18]. The other study used a different
plasmid (pNAGM) to study regulation of heat shock pro-
tein 30 in Aspergillus Oryzae [19]. The latter report con-
tained a figure similar to Figure 2 of this report. Both
research groups may find silencers, but they may also be
witnessing a plasmid-made artifact as in our case.
It is unclear why this phenomenon exists in our ovine
FSHBLuc  constructs. It may involve bringing backbone
plasmid sequences closer to the eukaryotic transcription
start site enabling a cryptic enhancer to increase expres-
sion until it overshadows induction by activin. Care has
been taken, however, to eliminate such effects by compa-
nies that sell expression plasmids. There might also be anReproductive Biology and Endocrinology 2009, 7:66 http://www.rbej.com/content/7/1/66
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effect caused by the packaging of closed circular DNA into
nucleosomal structures [20]. The mechanism is unclear,
but the phenomenon is real.
Ovine FSHB 3' sequences (exon/intron 1) were not needed 
for induction by activin A
Figure 4 also shows that replacement of the first 3' exon
(Rep 8) and intron 1 (Rep 9) had little or no effect on
activin A induction. Replacing intron 1 with neutral
sequence from the 5' promoter caused no difference in
basal or activin A-inducted expression compared to WT
expression. Likewise, replacing exon 1 with a synthetic oli-
gonucleotide (switching A/C and T/G) caused no signifi-
cant difference between induction by activin A compared
to WT induction. Based on these data, it was concluded
that 3' sequences in the first exon and intron (+7/+701
bp) were not required for activin A induction of ovine
FSHBLuc.
Activin A induction of ovine FSHBLuc with minimal promoters Figure 5
Activin A induction of ovine FSHBLuc with minimal promoters. (A) Induction of wild type ovine FSHBLuc by activin A 
was compared to induction of ovine FSHB(TK)Luc with a substitute thymidine kinase promoter (TK) placed between -40/+3 bp 
of ovine FSHBLuc. Induction of the parent TK construct is also shown. (B) Induction of wild type ovine FSHBLuc by activin A is 
compared to induction of ovine FSHB(rPRL)Luc with a substitute rat prolactin minimal promoter placed between -40/+3 bp of 
ovine FSHBLuc. Induction by these constructs was then compared to induction of the rat promoter construct lacking sequences 
known to be important for activin A induction Δ-175/-39 ovine FSHB(rPRL)Luc. The next construct contained the minimal rat 
prolactin promoter plus ovine 3'exon/intron 1, but lacked all 5' ovine sequence except the region between -200/-39 bp known 
to be important for activin A action (Rep 10). Finally, induction with activin A was measured for the original rat prolactin con-
struct. The data in Figure 5 are plotted as fold-induction since basal expression with the TK and rPRL promoters was increased 
20- and 8-fold, respectively, compared to basal expression with the wild type promoter. Bars represent the mean ± sem of 
results from quadruplicate cultures from a single and representative experiment. Means with different letters were statistically 
different from wild type induction (fold-induction). ANOVA and Tukey's multiple comparison analyses were used to determine 
significance where P ≤ 0.05.
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The importance of a minimal TATA box promoter
Figure 4 (Rep 7) shows that synthetically changing the 22
bp between the ovine TATA box and transcription start
site of wild type ovine FSHBLuc did not alter activin A
induction; there is no homology between wild type and
synthetic sequences (aggtgaactgagactagactcagc was
changed to caagaacaagaaatgcaacgcgtc). However, substitu-
tion of the TATA box region with the entire minimal TK
promoter (TK109) did destroy activin A induction (Figure
5A) as observed previously when the T81 promoter was
used. It may be that this promoter with its GC and CAAT
boxes increased basal expression so high (20-fold higher
than WT) that activin A action was overshadowed by basal
expression much like that observed with 5' deletions. Nev-
ertheless, the 20 bp between the TATA box and transcrip-
tion start site of rat prolactin (agtcaatgtctgcagatgag; no
homology to either ovine or synthetic sequences in Figure
4, Rep 7) also increased basal expression (8×) but fold
induction by activin A was fully preserved (Figure 5B). We
conclude that the TATA box is important, but that the
sequence between the TATA box and transcription start
site is unimportant.
The data in Figure 5B show that the minimal rat prolactin
promoter (with TATA box) did support maximal activin A
induction when the full length ovine FSHB promoter was
attached to it. When the distal 5' region was replaced with
apparently neutral sequences from the 3' human FSHB
coding gene, the rat promoter was still able to support
activin A induction as long as the construct contained
ovine sequences between -207/-39 bp. Deletion of the
ovine promoter between -175/-39 bp did destroy activin
A induction, as predicted, since these sequences are neces-
sary for activin A induction of wild type FSHBLuc expres-
sion in LbetaT2 cells [7-10]. Therefore, it was concluded
that the -169/-58 bp segment which is known to be essen-
tial for activin A induction of ovine FSHB promoter plus a
minimal TATA box comprise all necessary and sufficient
sequences required for activin A induction of ovine FSHB
expression, at least, in LbetaT2 cells.
Insights from transgenic studies
Both human and ovine FSHB genes have been success-
fully expressed as transgenes in mice and both are regu-
lated as if they were endogenous mouse FSHB  genes
[1,14]. The shortest 5' sequence tested with the human
gene contained -350 bp of 5' sequence. This includes the
region noted in this report (-169/-58 bp) along with the
human TATA box region. Clearly, there are other impor-
tant sequences in the human and ovine genes important
for gonadotrope expression as well. In the human gene
these sequences reside between + 3142 and +2138 in the
3' region of the gene [1]. As noted above, the ovine FSHB
gene needs sequences upstream of -750 bp [14], but both
human and ovine genes require proximal promoter
sequences within -300 bp of the transcription start site for
proper expression in vivo, which is consistent with the
data presented in this paper.
It will ultimately be important to confirm the conclusions
of the studies reported here in transgenic mice using arti-
ficial gene promoters containing only those sequences
thought important for gene expression and regulation. As
noted above for the ovine FSHB gene, there is still one
promoter element upstream of -750 bp that remains
undefined but necessary for gonadotrope expression [14].
This site must be defined before a synthetic promoter with
defined elements can be tested as a transgene in vivo.
LbetaT2 cells appear insensitive to this element so we are
currently investigating this site using viral constructs and
primary gonadotropes [2].
Conclusion
The combined data reported in this and previous studies
showed that the critical sequences for activin A induction
of ovine FSHBLuc are located between -169/-58 bp plus
the simple generic TATA box found in ovine FSHBLuc or
the rat prolactin promoter. Neither the distal 5' region (-
4741/-175 bp) nor 3' exon/intron sequences were found
important for activin A induction of ovine FSHBLuc in
LbetaT2 cells. The necessary and sufficient sequences for
activin A-inducible ovine FSHB expression comprise
sequences only between -169/-58 bp plus a minimal
TATA box promoter.
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